logo-loader
viewBlueJay Mining PLC

BlueJay Mining submits mining licence application for Dundas in Greenland

The defined mineral resource at Dundas stands at 117Mt at 6.1% ilmenite

BlueJay Mining PLC - BlueJay Mining submits mining licence application for Dundas in Greenland
Ilmenite is the main metal at Dundas

Bluejay Mining PLC (LON:JAY) has lodged its application to mine the Dundas ilmenite project in Greenland.

The Exploitation Licence covers the onshore portion of Dundas, which is estimated to produce annualised production of 440,000tpa.  

Currently, the defined mineral resource at Dundas stands at 117Mt at 6.1% ilmenite.

There is also a maiden offshore exploration target of between 300Mt and 530Mt of ilmenite at an average expected grade range of 0.4 to 4.8%. 

Once the application is deemed compliant and receives sign off from the Ministry of Mines, Bluejay will make the environmental and social impact assessments available for public scrutiny.

A ‘white-book’ will then be created based on the public feedback with a decision on whether to grant the licence to be made after that.

Bluejay did not give a timeline for the licence application.

Roderick McIllree, chief executive,  said: "Thanks to the extensive studies we have undertaken, the favourable Project economics and the support from our operational partners, we are confident of achieving the grant of an Exploitation Licence."

Quick facts: BlueJay Mining PLC

Price: 10.32 GBX

AIM:JAY
Market: AIM
Market Cap: £88.23 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BlueJay Mining PLC named herein, including the promotion by the Company of BlueJay Mining PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Allergy Therapeutics receives multi-million-dollar settlement

Top stories from the Proactive Investors UK newsroom. Allergy Therapeutics (LON:AGY) has accepted US$7.6mln in settlement of a dispute over the procedures used for a US grass pollen vaccine trial. Allergy blamed the inconclusive trial results on the way the study was carried...

on 27/6/19

2 min read